Heart Disease

What Causes High Blood Pressure?

Blood pressure is the term used to describe the pressure exerted on the arterial walls as blood flows through them. This pressure is at its highest when the heart contracts and pumps blood through the arteries and is called the systolic pressure.

Hypertrophic Cardiomyopathy Treatments

Why is Visceral Fat Dangerous?

Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

What are Drug-Eluting Stents?

Cardiothoracic Imaging Techniques

Heart Rate Abnormalities

Coronary Artery Disease Preventive Diets

What is a Heart Attack?

Drug-Eluting Stent Indications

What is Coronary Artery Disease?

Heart Attack Symptoms

See more featured articles »

Chronic Obstructive Pulmonary Disease Process

Obesity in Adults

Carotid Artery Stenosis Treatment

Chronic Obstructive Pulmonary Disease Diagnosis

Cardiovascular Benefits of Blueberries

Heartburn (Acid Reflux) Triggers

Heart Failure

Prognosis for Hypoplastic Left Heart Syndrome

What Causes A Heart Attack?

Coronary Artery Disease and Omega-3 Fatty Acids

Causes of Heartburn (Acid Reflux)

Cardiology Procedures

Coronary Artery Disease and Aspirin

Hypertension Symptoms and Effects

Drug-Eluting Stent Design

Dieting for Obese Children

Chronic Obstructive Pulmonary Disease Causes

Heart Attack Diagnosis

Pulmonary Rehabilitation for COPD

What is Cardiogenic Shock?

How is Acid Reflux Diagnosed?

Hypercholesterolemia and Hypocholesterolemia

Carotid Artery Stenosis Diagnosis

Cardiac Pharmaceutical Agents

LDL Cholesterol and Heart Disease

Cardiovascular Drugs

Coronary Artery Disease Characteristics

Heart Failure Diagnosis

Heart Failure Prognosis

Myocardial T1 and T2 Mapping

High Blood Pressure in Children

Obesity and Blood Pressure

What is Cholesterol?

High Blood Pressure Hypertension

Heart attack and cardiac arrest difference

Abdominal Obesity and the Metabolic Syndrome

Target Heart Rate

Chronic Obstructive Pulmonary Disease Treatment

Heart Failure Causes

History of Chronic Obstructive Pulmonary Disease

Hypertension Risk Factors

Lowering Risk for Cardiovascular Disease

Hypertension Treatment

Cardiogenic Shock Symptoms

Percutaneous Closure Procedure

Coronary Artery Disease Treatment

Cardiogenic Shock Diagnosis

Drug-Eluting Stent Alternatives

What is Obesity?

Heart Failure Management

Diagnostic Tests for Hypertrophic Cardiomyopathy

Structure and Function of the Heart

What is high cholesterol?

Hypertension Diagnosis

Heartburn (Acid Reflux) Prevention

Chronic Obstructive Pulmonary Disease Management

Foods that Reduce Heartburn (Acid Reflux)

Cardiothoracic Surgery

Heart Attack Questions

Drug-Eluting Stent Risks

Heart Rate Reserve

Cardiovascular Disease Diagnosis

What is Heartburn (Acid Reflux)?

Coronary Artery Disease Pathophysiology

Heart Failure Pathophysiology

Coronary Artery Disease Prevention

Coronary Artery Disease Angina

What is Cardiology?

Surviving Heart Attack

Hidden Signs of Heart Problems

Treatment of Hypoplastic Left Heart Syndrome

Anti-Hypertensive Drugs

What is Carotid Artery Stenosis?

Heart Failure Terminology

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Cardiovascular Disease Research

Cholesterol Physiology

What is Chronic Obstructive Pulmonary Disease?

Heart Attack Treatment

Hypoplastic Left Heart Syndrome (HLHS)

Chronic Obstructive Pulmonary Disease Symptoms

High Cholesterol and Stroke Risk

What is Cardiovascular Disease?

Hypertrophic Cardiomyopathy Symptoms and Causes

Hypertrophic Cardiomyopathy (HCM)

COPD and Sleep Apnea

Heart Disease Biomarkers and Screening Tests

Heartburn (Acid Reflux) Treatments

Cardiogenic Shock Treatment

Coronary Artery Disease Risk Factors

Photoplethysmography (PPG) for Heart Disease

Obesity and Metabolic Syndrome

Link between Bisphenol A and Increase in Blood Pressure

What is Heart Rate?

Heart Failure Classification

Diagnosis of Hypoplastic Left Heart Syndrome

Artificial Intelligence in Cardiology

Heart Failure Symptoms

Hypertrophic Cardiomyopathy Screening

How the Heart Pumps Blood

Latest Heart Disease News and Research

Short bursts of vigorous activity can lower risk of major diseases

People who get just a few minutes of vigorous activity daily are less likely to develop eight major diseases, including arthritis, heart disease and dementia, according to research published in the European Heart Journal today (Monday).

29 Mar 2026

Deferring PCI before TAVR shows comparable outcomes in elderly patients

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable outcomes regardless of whether they underwent percutaneous coronary intervention (PCI) before TAVR, according to findings from the PRO-TAVI study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Transcatheter valve-in-valve procedure improves short-term outcomes in high-risk patients

In patients with a poorly functioning bioprosthetic mitral valve in the heart, a minimally invasive procedure to insert a new valve was associated with a lower rate of death or disabling stroke within one year, compared with patients who underwent standard repeat mitral valve replacement surgery, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Minimally invasive valve repair lowers hospitalizations in heart failure patients

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received optimal medical therapy plus a minimally invasive procedure using a clip to repair the valve were significantly less likely to die, have a heart attack or stroke and 40% less likely to be hospitalized for heart failure compared with similar patients who were randomly assigned to optimal medical therapy alone.

29 Mar 2026

New drug sotatercept shows benefit in CpcPH-HFpEF patients

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and vascular health after taking the drug sotatercept, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Noninvasive lung impedance monitoring improves outcomes in HFpEF patients

Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with preserved ejection fraction (HFpEF), according to research presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Trial shows mavacamten benefits adolescents with obstructive heart condition

Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of blood flow obstruction in the heart, compared with those who received a placebo, according to a small study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Left-ventricular unloading during angioplasty fails to improve patient outcomes

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to support the heart in patients with both severe coronary heart disease and moderate to severe heart failure found no significant difference between the two approaches.

29 Mar 2026

Novel vFFR method performs similar to invasive coronary assessment

A novel, minimally invasive method of determining whether fatty deposits in a coronary artery are restricting blood flow to a patient's heart performed similarly to the standard, more-invasive procedure in a large multi-country European randomized trial presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

AI-based tool matches standard method for coronary blood flow assessment

A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient's heart performed similarly to the standard, more invasive wire-based procedure, according to a large international randomized trial presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Angioplasty improves symptoms in chronic total coronary occlusion patients

In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage of a coronary artery who received a nonsurgical procedure to reopen the artery showed statistically significant reductions in chest pain and improvements in quality of life compared with patients who received a placebo procedure.

29 Mar 2026

Intensive LDL cholesterol-lowering shows major benefits for heart disease patients

Using cholesterol-lowering medications more intensively to achieve a more aggressive target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular events by one-third among patients with atherosclerotic cardiovascular disease (ASCVD), according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

Evolocumab reduces cardiac events in high-risk diabetic patients

The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by nearly one-third among patients who had no known significant atherosclerosis and had diabetes, according to a study presented at the American College of Cardiology's Annual Scientific Session.

28 Mar 2026

Home-delivered DASH diet improves blood pressure and cholesterol outcomes

Black adults with high blood pressure who received dietitian counseling and home deliveries of groceries aligned with the DASH diet—meaning high in fruits, vegetables, whole grains, low-fat dairy, nuts, seeds, legumes and lean proteins—had an average overall reduction in systolic blood pressure of 7 mm Hg at three months overall and a 5 mm Hg reduction compared with participants who received only basic dietary guidance and a grocery stipend, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

Investigational drug lowers angiotensinogen but shows unclear blood pressure benefits

The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into the hormone that regulates blood pressure—caused a significant and sustained drop in angiotensinogen but its impact on blood pressure was less clear, according to a study presented at the American College of Cardiology's Annual Scientific Session.

28 Mar 2026

Intensive cholesterol‑lowering therapy reduces first major cardiac event in high‑risk patients with diabetes

Mass General Brigham researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high‑risk patients who did not have known atherosclerosis (the build-up of plaque inside artery walls) but did have diabetes.

28 Mar 2026

Hypercortisolism found in many patients with resistant hypertension

The MOMENTUM study found 27 percent of patients with resistant hypertension have hypercortisolism. This is a significant finding, demonstrating that hypercortisolism is more common in these patients than previously understood by researchers and clinicians.

28 Mar 2026

Microaxial flow pump fails to reduce heart damage in STEMI trial

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

28 Mar 2026

Catheter-based approach improves prognosis in pulmonary embolism patients

Patients who had low doses of clot-buster drugs delivered directly to the site of a pulmonary embolism (PE) via a catheter using ultrasound to enhance their effect had significantly better outcomes than those who received standard systemic anticoagulants, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

Temporary heart pump before PCI shows no significant benefit

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary angioplasty, for 30 minutes to reduce heart damage compared with standard immediate PCI in patients with heart attacks at risk for a large amount of heart damage found no significant difference between the two groups, the study's primary endpoint. The research was presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026